COVID
-
Metformin reduces Long COVID Rates: Study
In the COVID-OUT study, researchers from multiple academic institutions tested the effectiveness of three generic medications—metformin, ivermectin and fluvoxamine—in adults…
Read More » -
Dr Mansukh Mandaviya reviews covid management drugs with pharma cos
Dr Mandaviya appreciated and congratulated the pharma companies for their invaluable contribution during the covid pandemic in the country Union…
Read More » -
World’s first intra-nasal vaccine for covid by India bags CDSCO approval
The vaccine will be used for restricted use in emergencies in the age group of 18 and above World’s first…
Read More » -
7th World One Health Congress kickstarts in Singapore
The event seeks to advance the global One Health movement to improve health and well-being by preventing and mitigating crises…
Read More » -
ProteoGenix, Aseem Healthcare, Trident Biopharm announce antibody cocktail for SARS-CoV-2
A partnership between antibody development experts and global healthcare providers creates a new COVID-19 treatment for immunocompromised, high-risk, and vaccine…
Read More » -
CORBEVAX gets DCGI nod as heterologous COVID-19 booster dose
People who are 18 years and above and have already taken two doses of either COVISHIELD or COVAXIN can now…
Read More » -
HKUST researchers devise age-based eligibility method to measure vaccine effectiveness
Data-deficient countries will be informed while formulating and adjusting their vaccination and immunisation policies A research team from the Hong…
Read More » -
IHME forecasts enormous spread of Omicron
The research also forecasts around three billion infections to occur in the next two months Institute for Health Metrics and…
Read More » -
Pfizer’s antiviral pill cuts risk of severe covid by 89%
The company plans to submit interim trial results for its pill to the US Food and Drug Administration as part…
Read More »